Further, TRIB1 overexpression correlated with poor overall survival and multi-drug resistance, and was found in cisplatin-pretreated NSCLC, dependent on CEBPB regulation [119]. The gene discussed is TRIB1; the disease is non-small cell lung carcinoma.